Search research articles
Contact Us
Filters
Showing results (31-40 of 39) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 39 results.
The Journal of Biological Chemistry
|
February 1, 2007
Activation mechanism and steady state kinetics of Bruton's tyrosine kinase
Marie Dinh, Dorit Grunberger, Hoangdung Ho, et al.
Hepatology (Baltimore, Md.)
|
March 21, 2012
Transcriptomic analysis of the woodchuck model of chronic hepatitis B
Simon P Fletcher, Daniel J Chin, Yongmei Ji, et al.
British Journal of Pharmacology
|
March 18, 2014
A study of the molecular mechanism of binding kinetics and long residence times of human CCR5 receptor small molecule allosteric ligands
David C Swinney, Paul Beavis, Kai-Ting Chuang, et al.
Journal of Pharmaceutical Sciences
|
September 27, 2014
The biopharmaceutics risk assessment roadmap for optimizing clinical drug product performance
Arzu Selen, Paul A Dickinson, Anette Müllertz, et al.
The Journal of Biological Chemistry
|
April 16, 2002
A small molecule ubiquitination inhibitor blocks NF-kappa B-dependent cytokine expression in cells and rats
David C Swinney, Yi-Zheng Xu, Liliana E Scarafia, et al.
Antiviral Research
|
May 18, 2010
Biochemical characterization of the inhibition of the dengue virus RNA polymerase by beta-d-2'-ethynyl-7-deaza-adenosine triphosphate
Derek R Latour, Andreas Jekle, Hassan Javanbakht, et al.
Plos Pathogens
|
March 30, 2016
Correction: Intrahepatic Transcriptional Signature Associated with Response to Interferon-α Treatment in the Woodchuck Model of Chronic Hepatitis B
Simon P Fletcher, Daniel J Chin, Lore Gruenbaum, et al.
Plos Pathogens
|
September 10, 2015
Intrahepatic Transcriptional Signature Associated with Response to Interferon-α Treatment in the Woodchuck Model of Chronic Hepatitis B
Simon P Fletcher, Daniel J Chin, Lore Gruenbaum, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 26, 2011
3-Amino-pyrazolo[3,4-d]pyrimidines as p38α kinase inhibitors: design and development to a highly selective lead
Michael Soth, Sarah Abbot, Allassan Abubakari, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 39) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 39 results.
The Journal of Biological Chemistry
|
February 1, 2007
Activation mechanism and steady state kinetics of Bruton's tyrosine kinase
Marie Dinh, Dorit Grunberger, Hoangdung Ho, et al.
Hepatology (Baltimore, Md.)
|
March 21, 2012
Transcriptomic analysis of the woodchuck model of chronic hepatitis B
Simon P Fletcher, Daniel J Chin, Yongmei Ji, et al.
British Journal of Pharmacology
|
March 18, 2014
A study of the molecular mechanism of binding kinetics and long residence times of human CCR5 receptor small molecule allosteric ligands
David C Swinney, Paul Beavis, Kai-Ting Chuang, et al.
Journal of Pharmaceutical Sciences
|
September 27, 2014
The biopharmaceutics risk assessment roadmap for optimizing clinical drug product performance
Arzu Selen, Paul A Dickinson, Anette Müllertz, et al.
The Journal of Biological Chemistry
|
April 16, 2002
A small molecule ubiquitination inhibitor blocks NF-kappa B-dependent cytokine expression in cells and rats
David C Swinney, Yi-Zheng Xu, Liliana E Scarafia, et al.
Antiviral Research
|
May 18, 2010
Biochemical characterization of the inhibition of the dengue virus RNA polymerase by beta-d-2'-ethynyl-7-deaza-adenosine triphosphate
Derek R Latour, Andreas Jekle, Hassan Javanbakht, et al.
Plos Pathogens
|
March 30, 2016
Correction: Intrahepatic Transcriptional Signature Associated with Response to Interferon-α Treatment in the Woodchuck Model of Chronic Hepatitis B
Simon P Fletcher, Daniel J Chin, Lore Gruenbaum, et al.
Plos Pathogens
|
September 10, 2015
Intrahepatic Transcriptional Signature Associated with Response to Interferon-α Treatment in the Woodchuck Model of Chronic Hepatitis B
Simon P Fletcher, Daniel J Chin, Lore Gruenbaum, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 26, 2011
3-Amino-pyrazolo[3,4-d]pyrimidines as p38α kinase inhibitors: design and development to a highly selective lead
Michael Soth, Sarah Abbot, Allassan Abubakari, et al.
Page
of 4